O’Donnell MR 1

Date of preparation: February 6, 2017

Max Roe O’Donnell, MD, MPH 622 W 168th St

PH 8 E 101 NY, NY 10032

mo2130@ columbia.edu ACADEMIC APPOINTMENTS, HOSPITAL APPOINTMENTS, AND OTHER WORK EXPERIENCE

Academic Appointments

05/2014 – Present Columbia University Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine Assistant Professor of Medicine at CUMC

New York, NY

05/2014 – Present Columbia University Mailman School of Public Health

Assistant Professor of Epidemiology at CUMC New York, NY

05/2014 – Present 01/2013 – 05/2014

Albert Einstein College of Medicine Adjunct Assistant Professor of Medicine, Division of Pulmonary Medicine Albert Einstein College of Medicine/Montefiore Medical Center Associate Program Director, Pulmonary Critical Care Fellowship

Bronx, NY Bronx, NY

01/2012 – 05/2014

Albert Einstein College of Medicine/Montefiore Medical Center Assistant Professor (Secondary Appointment) of Epidemiology and Population Health

Bronx, NY

07/2010 – 05/2014

Albert Einstein College of Medicine

Assistant Professor of Medicine, Division of Pulmonary Medicine

Bronx, NY

Hospital Appointments

05/2014 – Present New York-Presbyterian/Columbia University Medical Center Attending Physician, Division of Pulmonary, Allergy, and Critical Care Medicine

New York, NY

07/2010 – 05/2014 Montefiore Medical Center

Attending Physician, Division of Pulmonary Medicine Bronx, NY

07/2010 – 5/2014 Jacobi Medical Center Attending Physician, Medical Intensive Care Unit

Bronx, NY

Other Appointments

05/2014 – Present Fort Greene Chest Clinic, Bureau of Tuberculosis Control, Department of Health and Mental Health Volunteer Tuberculosis Physician

Brooklyn, NY

05/2014-Present Centre for AIDS Programme of Research in South Africa (CAPRISA) Durban, South Africa Associate Researcher

O’Donnell MR 2

08/2016-Present BioMed Central Infectious Diseases Associate Editor 01/2017-Present AnnalsATS New York City, NY Associate Editor EDUCATION

08/1998 – 05/2003 Tufts University School of Medicine MD, May 2003

Boston, MA

08/1998 – 05/2003 Tufts University School of Medicine

MPH, May 2003 Boston, MA

08/1991 – 05/1995 St. John’s College BA, Liberal Arts, May 1995

Santa Fe, NM

TRAINING

Post-Graduate Training

06/2006 – 06/2010 Boston University School of Medicine Fellow, Pulmonary and Critical Care Medicine

Boston, MA

06/2006 – 06/2010 Centre for AIDS Programme of Research in South Africa (CAPRISA) Research Fellow

Durban, South Africa

06/2006 – 06/2009 Boston University Trainee, Clinical HIV/AIDS Research Training Program (BU-CHART)

Boston, MA

06/2006 – 06/2009 Boston University Fellow, Clinical Research Training Scholar Track (CREST)

Boston, MA

06/2003 – 06/2006 Columbia University Medical Center Resident, Internal Medicine

New York, NY

Other Training

06/2016 McGill University Infectious Diseases Epidemiology Course

Montreal, Canada

03/2016 Cold Spring Harbor Laboratory Leadership in Bioscience

Huntington, NY

10/2014 Columbia University Medical Center Reach for the First R01

New York, NY

06/2014 Extracorporeal Life Support Organization (ELSO) Extracorporeal Membrane Oxygenation (ECMO) training

Iowa City, IA

06/2011 Albert Einstein College of Medicine Grant Writing Course

Bronx, NY

06/2011 Columbia Mailman School of Public Health Statistical Programming for Epidemiology (SAS), EPIC

New York, NY

O’Donnell MR 3

06/2006 Boston University School of Public Health ‘Modern Epidemiology’ course

Boston, MA

06/2006 Boston University School of Public Health ‘Infectious Diseases Epidemiology’ course

Boston, MA

LICENSURE AND BOARD CERTIFICATION

2009 Board Certified in Critical Care Medicine, ABIM 2008 Board Certified in Pulmonary Medicine, ABIM 2006 Board Certified in Internal Medicine, ABIM HONORS AND AWARDS

2015 Doris Duke Clinical Scientist Development Award 2015 Louis V. Gerstner Scholars Award 2012 Institute for Clinical and Translational Research. Washington, DC, Keynote speaker 2009 International AIDS Society/Agence nationale des recherches sur le sida Young Investigators Award (Best Clinical Abstract by a Young Investigator IAS Conference 2009) 2009 NIH Ruth Kirschstein Individual Post-Doctoral Fellowship (F-32) 2009 American Thoracic Society Career Development Award 2006 Rudin Clinical Ethics Fellow, Columbia University Medical Center 2005 Yale/Johnson & Johnson Physician Scholar in International Health 2003 Loeb Memorial Prize in Medicine (Tufts University) 2003 Berman Travel Scholarship (Tufts University) 2003 First Prize Charlton Poster Contest (Tufts University refereed contest for graduate research in medicine,

biological, dental and veterinary science) 2002 Tufts University College of Citizenship and Public Service (UCCPS) grant recipient 1995 Thorne Scholarship Recipient 1994 Thorne Scholarship Recipient ACADEMIC SERVICE

Departmental/Divisional Activities

Columbia University Medical Center, Columbia Mailman School of Public Health (2014-present) 2015 – Present Interview Columbia Internal Medicine Residency candidates 2014 – Present Interview Columbia Pulmonary/Critical Care fellow candidates 2014 – Present Masters in Public Health Admissions Committee member 2014 – Present Advisor to ~5 Masters in Public Health students annually 2014 – Present First reader for Masters in Public Health students’ theses (thesis advisor) 3-5 students annually 2014 – Present Discussant at Internal Medicine Housestaff Morning Report 2016 – Present Worked with colleagues to develop the Global Health Research Pathway within Columbia Pulmonary

Critical Care Fellowship

O’Donnell MR 4

Albert Einstein College of Medicine (2010-2014) 2011 – Present Interviewed Pulmonary/Critical Care fellow candidates x 5 sessions annually 2013 – 2014 Associate Program Director, Montefiore/Einstein Pulmonary Fellowship 2011 – 2014 Scheduled the bi-weekly Einstein Pulmonary divisional conferences, which involved inviting outside

speakers, coordinating interdepartmental and interdivisional conferences, and ensuring that fellows have sufficient opportunities to present and topics covered satisfy ACGME requirements.

2011 – 2014 Started a research mentoring program for Einstein/Montefiore Pulmonary/Critical Care fellows, which included a formal lecture series and one-on-one mentoring. This resulted in our fellows winning 4/5 best research posters in an annual internal Department of Medicine research poster competition in 2014.

2011 – 2014 Started a presentation mentor program for Pulmonary/Critical Care fellows involving pairing each fellow presenter with a faculty mentor to ensure high quality divisional presentations

2011 – 2012 Interviewed Montefiore Internal Medicine Residency candidates x 4 sessions annually

Other Professional Activities

2017 Facilitator, Molecular mechanisms of Tuberculosis Transmission Symposium, American Thoracic Society,

Washington D.C.

2017 Multidrug-resistant and Extensively drug resistant tuberculosis. Sunrise session. Presenter. American

Thoracic Society, Washington D.C.

2016 American Thoracic Society International Conference Abstract Reviewer

2016 Faculty Discussion Facilitator, “Tuberculosis Case Reports”, 2016 American Thoracic Society Conference,

San Francisco, CA

2016 – Present Member, Program Committee, Microbiology, Tuberculosis & Pulmonary Infections, American Thoracic

Society

2014 – Present Research Director, East Africa Training Initiative (EATI), Addis Ababa, Ethiopia funded by Vital Strategies

Responsibilities include travel to Ethiopia annually to supervise fellows in clinical and research work and

hosting EATI fellows annually at Columbia for a 3 week training visit.

2016 Member, Special Emphasis Panel, NIH/NIAAA, CONSORTIA FOR HIV/AIDS AND ALCOHOL- RELATED RESEARCH TRIALS (CHAART)

2015, 2016 External grant reviewer, Medical Research Council, UK

2015 - 2017 Member, NIH SBIR Study Section for Inhalational Agents for TB treatment

2015 Member, Research Competitiveness Program, American Association for the Advancement of Science

(AAAS)

2014 External Grants Reviewer, University of Washington, Seattle, Center for AIDS Research (CFAR)

2014 – Present Abstract Reviewer for Union World Conference on Lung Health

2014 – Present Bio-containment Intensive Care Unit (BICU) team member

New York-Presbyterian Hospital was selected as one of the first 35 such hospitals in the United States to

train for management of highly transmissible emerging infectious diseases. BICU volunteers received

didactic education and train using simulations.

2014 Invited Outside Reviewer, NHLBI Study Section, ZHL1-CSR-B-M1

2014 Member, NIAID Special Emphasis Panel, Centers for AIDS Research

2013 NIAID Study Section Invited Special Emphasis Panel Member, AIDS Clinical Trials Unit Study Section

Meeting ZAI1-JBS-A-S3

2013 Invited Speaker Center

O’Donnell MR 5

2013 NIH Invitee, ‘NIH Clinical Research Day’, Bethesda, MD

2013 Bill and Melinda Gates Invitee, ‘Rapid TB Drug Susceptibility Testing Consortium Workshop’

2012, 2015 External Grants Reviewer, Medical Research Council, South Africa

2012 – 2014 Data Safety and Monitoring Board, ALIVE trial

2012 Faculty Facilitator, “Case Reports of Unusual Pulmonary Infections”, 2012 American Thoracic Society

Conference, San Francisco, CA

2009 – Present Abstract Mentor for International AIDS Society Conference

Peer Review

2015 Peer Reviewer, BMC Research Notes

2014 – 2016 Peer Reviewer for PLoS Medicine

2013 – 2015 Peer Reviewer, Annals of Pulmonary Medicine

2013 – 2014 Peer Reviewer, The Lancet

2013 Peer Reviewer, Journal of Infectious Diseases

2013 Peer Reviewer, Tuberculosis

2013 Peer Reviewer, Journal of Acquired Immunodeficiency Syndrome

2012 – 2016 Peer Reviewer, BMC Infectious Diseases

2012 – 2015 Peer Reviewer, Clinical Infectious Diseases

2012 Peer Reviewer for Bulletin of the World Health Organization

2012 Peer Reviewer for Emerging Infectious Diseases

2012 Peer Reviewer for Journal of the American Medical Association

2012 Peer Reviewer, American Journal of Respiratory and Critical Care Medicine

2012 Peer Reviewer, The Lancet Infectious Diseases

2011 Peer Reviewer for International Journal of Tropical Medicine

2011 Peer Reviewer Journal of Occupational Health Southern Africa

2010 – 2015 Peer Reviewer for PLoS One

2010 – 2011 Peer Reviewer for Annals of Internal Medicine

2009 – 2016 Peer Reviewer International Journal of Tuberculosis and Lung Disease

2015 – 2017 Peer Reviewer AnnalsATS

PROFESSIONAL ORGANIZATIONS AND SOCIETIES

2009 – Present Member, International AIDS Society 2008 – Present Member, American College of Chest Physicians 2006 – Present Member, American Thoracic Society 2006 – Present Member, International Union Against Tuberculosis and Lung Disease

O’Donnell MR 6

FELLOWSHIP AND GRANT SUPPORT

Present Support

1. NIH/NIAID, K23 AI098479-01A1

O’Donnell (PI) 7/1/2012-6/31/2017 Title: A Biomarker to Rapidly Measure XDR-TB Treatment Response and New Second-line Drug Resistance in an HIV Endemic Setting Effort: 8 calendar months

2. New Faculty Initial Funding, Division of Pulmonary, Allergy, and Critical Care Medicine, CUMC 7/2014-6/2017 Project funding; No effort

3. Louis V. Gerstner Family Foundation Scholar. O’Donnell (PI) 7/2015-6/2018 Effort: 1.2 calendar months

4. Doris Duke Charitable Foundation Clinical Scientist Development Award O’Donnell (PI) 7/2015-6/2018 Effort: 1.2 calendar months

5. NIH/NIAID, 1R01AI114900-03 Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence Larsen (PI), O’Donnell (Co-investigator) Effort: 1.8 calendar months (in kind for 2016, starting 2017 paid effort)

6. NIH/NHLBI T32 HL105323 04 COLUMBIA UNIVERSITY TRAINING PROGRAM IN LUNG SCIENCE BHATTACHARYA (PI) O’Donnell (mentor) (in kind)

7. Stony Wold Herbert Foundation. Grant in Aid. Adherence support for drug-resistant TB HIV co-infection. O’Donnell (PI) 10/2014 – 10/2015 (no cost extension) 8. Stony Wold Herbert Foundation. Mentored Training Award. Cummings, M. (trainee) O’Donnell, M (mentor) (in

kind) 9. New York Academy of Medicine, David E. Roberts Fellowship. Bionghi, N (trainee) O’Donnell, M (mentor) (in kind) 10. NIH/NIAID R01AI124413-01 (MPI) GRANT11969016 Promoting Engagement in the Drug Resistant

TB/HIV Care Continuum in South Africa O’Donnell M (PI) Effort 2.4 calendar months. 4/10/2016-3/31/2021 11. Columbia University College of Physicians and Surgeons Summer 2016 Research Program for Medical Students.

Bionghi, N (trainee) O’Donnell, M (mentor) (in kind) 12. CAMPR Phase I+ Phase II funding, Next generation sequencing and inferential forecasting to characterize and

predict epidemic severe acute respiratory infection in Uganda O’Donnell M (PI) 4/10/2016-7/1/2017 (in kind) Past Support (past 3 years)

1. NIH/NIAID R56 R56AI06543

7/1/2013-6/31/2014 O’Donnell (Co-investigator) Jacobs WR (PI) Reporter Phages for Diagnosis of Drug-Resistant TB in HIV High-Burden Populations

2. NIH/NIAID, T32 T32AI070117-06A1

Kim (PI) Tanowicz (PI) 15/JUN/2014-31/MAY/2019 Title: Geographic Medicine and Emerging Infections

3. Clinical and Translational Research Institute, Albert Einstein College of Medicine, Career Development Award (KL2) O’Donnell (PI) 7/1/2011-6/30/2014 Title: A Novel Biomarker for Treatment Response in Drug-Resistant Tuberculosis 4. National Institutes of Health (NIH), National Institutes of Allergy and Infectious Disease (NIAID),Ruth Kirschstein

NSRA F-32 Individual Post-Doctoral Fellow Award O’Donnell (PI) 7/01/2009-6/30/2010 Title: Treatment Outcomes for Patients with Extensively Drug Resistant Tuberculosis

O’Donnell MR 7

A pilot prospective study of treatment of XDR-TB looking for clinical variables and risk factors associated with treatment outcomes. Role: PI

5. Center for Global Health, Albert Einstein College of Medicine, Pilot Grant O’Donnell (PI) 12/31/2010- 12/30/2011

Title: The Evolution of Resistance to Moxifloxacin among Extensively Drug Resistant Tuberculosis (XDR-TB) Patients on Treatment in South Africa

6. American Thoracic Society (ATS), Career Development Award

O’Donnell (PI) 7/01/2009-6/30/2010 Title: Treatment Outcomes for Patients with Extensively Drug Resistant Tuberculosis and HIV. A prospective study of treatment outcomes and epidemiologic risk factors among XDR-TB/HIV co-infected patients. Role: PI

7. Potts Memorial Foundation (Schenectady, NY)

Horsburgh (PI) 1/01/09 – 1/01/10 Title: Improving Care and Treatment Outcomes for Extensively Drug Resistant Tuberculosis Patients in South Africa. This project seeks to enhance care for extensively drug resistant tuberculosis patients in Kwazulu-Natal, South Africa by using a combination of training, and improved clinical data collection. Role: Collaborator

8. 2R01 DA19841-06 NIH/NIDA

Cotton (PI) 07/01/05 - 06/30/10 Title: Natural History of Hepatitis C Infection in HIV Disease A sub-study of incidence and risk factors for latent TB infection using an interferon gamma release assay among a cohort of HCV infected injection drug users with and without HIV infection. Role: Trainee/Collaborator

9. T32 AI52074-02 NIH/NIDA

Horsburgh (PI) 08/01/03 - 05/31/10 Title: Boston University HIV/AIDS Clinical Research Training Program My project through this training grant was the analysis of TB disease and latent infection among a community based cohort in the rural Southeastern U.S. with a significant burden of HIV infection. Role: Trainee

10. Stony Wold-Herbert Foundation, Grant-in-Aid O’Donnell (PI) Original grant: 7/1/2011-6/31/2012; Renewal grant: 7/1/2013- 6/31/2014

Title: The Molecular Epidemiology of Emergent Drug Resistance among Extensively Drug Resistant Tuberculosis (XDR-TB) Patients on Treatment in South Africa

O’Donnell MR 8

EDUCATIONAL CONTRIBUTIONS

Lectures/Teaching

Albert Einstein College of Medicine (2010-2014)

2014 Guest course lecturer, Epidemiology of Tuberculosis, Columbia Mailman School of Public Health, NY, NY

2013 Guest course lecturer, Epidemiology of Infectious Diseases course, Tufts University School of Medicine,

Boston, MA

2010 – 2014 Pulmonary Division conference presentations approx. 4x/year including topics such as original research,

non-tuberculosis mycobacteria, latent TB infection, epidemiologic methods, and core topics such as

pulmonary embolism

2010 – 2014 Noontime lectures to Montefiore Internal Medicine housestaff on pulmonary topics approx. 4

lectures/year

2010 – 2014 Case based learning facilitator for 2nd year medical students 2x/year including topics such as tuberculosis,

lung cancer, COPD, pulmonary vascular disease

Columbia University Medical Center, Columbia Mailman School of Public Health (2014-present)

2016 Organized symposium: World TB Day 2016 Global is Local: Opportunities and

Challenges for TB Elimination in New York City. March 21, 2016.

Website: wtbd2016.net

2015 Organized symposium: Re-inventing adherence: toward a patient-centered approach to drug-resistant

TB/HIV treatment at the Columbia Mailman School of Public Health March 19,20, 2015. Website: Tbhiv-

colloq.org

2015 – Present Columbia TB Research Group. Bi-monthly meeting to pull together all TB researchers in the Columbia

community. Co-organizer with Drs. Barun Mathema and Yael Hirsch-Moverman

Mentoring

Mentee Name Project Output Current Position

Murali Gopal Clofazimine in the

Treatment of Multidrug

Resistant Tuberculosis

Abstract ATS; Columbia University affiliated

Pulmonologist

Oral Presentation World Lung Health Conference

Review article (published International Journal of

Tuberculosis and Lung Disease 2013, see

Bibliography), Original Article (published Journal of

Antimicrobial Chemotherapy, 2014 see

Bibliography)

Robert Hicks Multidrug Resistant

Tuberculosis in South

African Children

Abstract awarded Second prize Einstein Research

Day

2nd year radiology resident,

University of California, San

Francisco

Abstract American Thoracic Society 2013

O’Donnell MR 9

Microgrant through Einstein Global Health Center

Nirmal Sharma Temporal Trends in

Drug-Resistant

Tuberculosis in KwaZulu-

Natal

Abstract ATS 2013 Fellow PCCM, University of

Alabama, Birmingham

Christian Ascioli Molecular Epidemiology

of Tuberculosis in

TB/HIV patients in

Guatemala

Abstract Chest 2013, World Lung Health

Conference 2013

Fellow PCCM, University of

Illinois, Chicago

Alfredo Chang

Lee

Reporter Phage for

Detecting Macrolide

Drug Resistance in M

Avium

Abstract on Rapid Macrolide Resistance Diagnosis

presented American Thoracic Society 2014

Assistant Professor, Keck School

of Medicine, University of

Southern California, Los Angeles,

CA

Delay to Treatment in

Pediatric MDR-TB

Abstract Submitted to Chest 2013; Abstract ‘Delay

to Diagnosis and Delay to Treatment in Children

with MDR-TB and HIV’ won Second Prize at

Montefiore Residents Research Day

Eric Kalivoda* Development of Novel

Persister Phages to

Detect MTB Persisters

Abstract Keystone TB Conference 2013, ; Abstract

American Thoracic Society awarded ATS Abstract

Scholarship prize

ED Resident, St John’s Hospital,

Detroit

Keira Cohen* Beta-Lactamase

Susceptibility in XDR-TB

Abstract Presented Keystone TB Conference 2013, PCCM Fellow, Brigham and

Women’s Hospital

Abigail Chua Foreign Born Initiative to

Improve Access to Care

for TB Patients in New

York with DOHMH

Abstract 2014 American Thoracic Society Critical Care Fellow, Montefiore

Medical Center, Bronx, NY

Matt Cummings Diagnostic tests for TB

Bacteremia; Molecular

Epidemiology of Severe

Acute Respiratory

Infection in Uganda

Abstract 2014 American Thoracic Society

“Inverting the pyramid: Mycobacterium

tuberculosis bacteremia” 2015 IJTLD. See

Bibliography.

Chief Resident, Internal Medicine

Training Program, Columbia

University Medical Center

Neelima

Navuluri

Prospective Study of

Adverse Drug Reactions

in XDR-TB/HIV

treatment

Abstract 2015 American Thoracic Society 3rd year Internal Medicine

Resident, Columbia University

Medical Center

Haider Ali Analyzing the utility of

mediastinoscopy in HIV-

positive patients with

asymptomatic bilateral

hilar lymphadenopathy

Abstract 2015 American Thoracic Society Pulmonary Critical Care Fellow,

Emory University

O’Donnell MR 10

* Co-mentor

Teaching Reviews

1. Einstein/Montefiore Pulmonary/Critical Care Fellows Reviews

2010-2013 Thirteen Fellow reviews.

Median score 8 (9 highest possible score) (Range 7-9)

2. Montefiore Medical Center Ward Medicine Resident Reviews 2012

Sample Comments from Montefiore/Einstein Internal Medicine Housestaff; 2012. Original documents available.

………..

All numeric scores were 9 (highest possible).

Comment #1: Dr O'Donnell is a lot of fun to work with. He tried to make every patient a teaching example and I

appreciated his efforts to further my learning.

3. Jacobi Medical Intensive Care Unit Resident Reviews 2011-2013

Sample Comments from Jacobi Internal Medicine House Staff teaching reviews on Medical ICU Rotation; 2011-2013

Original documents available.

…………….

All numeric scores were either 4 or 5 (5 highest possible).

Comment #1: Dr. ODonell is a great attending. He is able to go over each case and discuss the finer points associated with

each case during rounds

Comment #2: very good attending, teaches much, supports his decisions in literature, always supportive of the housestaff.

Would gladly work with him again.

Marne

Garretson

Temporal trends in drug-

resistant TB/HIV

treatment in South

Africa

Abstract 2015 American Thoracic Society Program Analyst, Montefiore

Health System

Kay Yeungling

Treatment outcomes

with extensively drug-

resistant TB HIV

Abstract 2016 World AIDS Conference, Durban Study Coordinator, ICAP,

Columbia University

Neda Bionghi New and repurposed

antibiotics for XDR-TB

David E. Roberts Fellowship,

New York Academy of Medicine;

Columbia University T35 funded awardee for

summer research

2nd year medical student

Columbia University

O’Donnell MR 11

Comment #3: Has a vast amount of knowledge regarding current research and accepted guidelines regarding patient

managment protocol and therefore encouraged us to read more current advances when possible. As well, very organised

in managing residents and patients in making the ICU experience efficient and not tiring.

Comment #4: Outstanding attending. very approachable, encourages learning and goes the extra mile for the patients.

Comment #5: Dr. O'Donnell is great with regards to enforcing evidence based medicine in his daily rounds routine, his

manner of rounding and citing articles stimulates learning and reading; also aside from having good clinical skills he is

always questioning and encouraging possible research with a broad knowledge of how to interpret and apply medical

literature.

……….

4. Teaching Reviews CUMC 2015-2016:

Comment #1: I liked that Dr. Odonnell made an effort to see all the sick patients with the triage resident. He also is very

directed and effective in terms of prioritization and the role of the triage team

Comment #2: We had some really intense triage days and Dr. O'Donnell was a wonderful attending to work with. He was

supportive and helpful, he taught, and was friendly.

Comment #3: Helpful attending to work with on triage, helpful in navigating system

Report of Clinical and Public Health Activities and Innovations

• Practice or Public Health Activities

- ICU and critical care services attending 12 weeks per year since 2014 - Inpatient Pulmonary consult 2.25 weeks per year - Special procedures delineated on practice form include inter alia bronchoscopy, emergent

intubation, chest tube placement, central venous catheter placement, interpreting chest radiography, thoracic and critical care ultrasound and pulmonary function tests.

• Additional Clinical or Public Health Service Activities - Voluntary physician at DOHMH Chest clinic, Fort Greene, Brooklyn 2014- Present, 1 day per month

PUBLICATIONS

Original, Peer Reviewed Articles

1. Zelnick JR, O'Donnell MR, Ahuja SD, Chua A, Sullivan Meissner J. Healthcare provider perspectives on tuberculosis care for foreign-born populations in New York City. Int J Tuberc Lung Dis. Nov 2016 2. O'Donnell MR, Padayatchi N, Metcalfe JZ. Elucidating the role of clofazimine for the treatment of tuberculosis.

O’Donnell MR 12

Int J Tuberc Lung Dis. Nov 2016 3. Jain P, Weinrick BC, Kalivoda EJ, Yang H, Munsamy V, Vilcheze C, Weisbrod TR, Larsen MH, O'Donnell MR, Pym A, Jacobs WR Jr. Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum. mBio. 2016; 7(5). PubMed [journal]PMID: 27795387 PMCID: PMC5080378 4. Cummings MJ, Bakamutumaho B, Kayiwa J, Byaruhanga T, Owor N, Namagambo B, Wolf A, Wamala JF, Morse SS, Lutwama JJ, O'Donnell MR. Epidemiologic and Spatio-Temporal Characterization of Influenza and Severe Acute Respiratory Infection in Uganda, 2010-2015. Annals of the American Thoracic Society. 2016; PubMed [journal]PMID: 27612095 5. Huang H, Yu X, Gu Y, Jiang G, Ma Y, Zhao L, Sun Z, Jain P, O’Donnell M, Larsen MH, Jacobs WR Jr Evaluation of a high-intensity green fluorescent protein fluorophage method for drug- resistance diagnosis in tuberculosis for Isoniazid, Rifampin and Streptomycin. Frontiers in microbiology. 2016; 7 (922)

6. O'Donnell MR, Padayatch N, Metcalfe, JZ. Elucidating the role of clofazimine for the treatment of tuberculosis. Int J Tuberc Lung Dis. 2016 Accepted April 21st. 7. Zelnick JR, O’Donnell MR, Ahuja SD, Chua A, Sullivan Meissner J. Healthcare provider perspectives on tuberculosis care for foreign-born populations in New York City. Int J Tuberc Lung Dis. 2016 Accepted June 21st.

8. Padayatchi N, Naidu N, Yende-Zuma N, O’Donnell MR, Naidoo K, Augustine S, Zumla A, Loveday M. Clinical Impact of the Xpert MTB/RIF Assay in Patients with Multi-Drug Resistant Tuberculosis. JAIDS Journal of Acquired Immune Deficiency Syndromes: Accepted June 13, 2016

9. Cummings MJ, Bakamutumaho B, O’Donnell MR. Unfinished business: severe acute respiratory infection in sub-Saharan Africa. Intensive care medicine. Accepted May 12, 2016.

10. O'Donnell MR, Daftary A, Frick M, Hirsch-Moverman Y, Amico KR, Senthilingam M, Wolf A, Metcalfe JZ, Isaakidis P, Davis JL, Zelnick JR, Brust JC, Naidu N, Garretson M, Bangsberg DR, Padayatchi N, Friedland G. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2016 Apr;20(4):430-4.

11. Desjardins CA, Cohen KA, Abeel T, Manson McGuire A, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Earl AM, Pym AS. Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. Nature Genetics. Accepted for publication April 2016.

12. Cohen KA, Abeel T, Manson McGuire A, Desjardins CA, Munsamy V, Shea TP, Walker BJ, Bantubani N, Almeida DV, Alvarado L, Chapman SB, Mvelase NR, Duffy EY, Fitzgerald MG, Govender P, Gujja S, Hamilton S, Howarth C, Larimer JD, Maharaj K, Pearson MD, Priest ME, Zeng Q, Padayatchi N, Grosset J, Young SK, Wortman J, Mlisana KP, O'Donnell MR, Birren BW, Bishai WR, Pym AS, Earl AM. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLoS Med. 2015 Sep 29;12(9):e1001880. doi: 10.1371/journal.pmed.1001880. 13. Moving Beyond Directly Observed Therapy for Tuberculosis. Metcalfe JZ, O'Donnell MR, Bangsberg DR. PLoS Med. 2015 Sep 15;12(9):e1001877 14. O'Donnell MR, Pillay M, Pillay M, Werner L, Master I, Wolf A, Mathema B, Coovadia YM, Mlisana K, Horsburgh CR, Padayatchi N. 2015. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With

O’Donnell MR 13

Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 69:536-543.PMID: 25886924 15. O'Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Jacobs WR, Jr., Larsen MH. 2015. A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population. J Clin Microbiol 53:2188-2194.PMID: 25926493

16. Cummings M, O’Donnell MR. Inverting the pyramid: increasing awareness of mycobacterial sepsis in sub-Saharan Africa. Int J of Tuberc and Lung Dis. 2015; 19(10):1128-1134. 17. Padayatchi N, Gopal M, Naidoo R, Werner L, Naidoo K, Master I, O'Donnell MR. 2014. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study. J Antimicrob Chemother 69:3103-3107. 18. O'Donnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N. 2014. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study. J Acquir Immune Defic Syndr 67:22-29.PMID: 24872138 19. Hicks RM, Padayatchi N, Shah NS, Wolf A, Werner L, Sunkari VB, O’Donnell MR. Malnutrition is Associated with Unfavorable Outcome and Death Among South African MDR-TB HIV Co-infected Children. Intl J Tuberc and Lung Dis. 2014; 18:1074-83. PMID: 25189555 20. Daftarya A, Padayatchi N, and O’Donnell MR. Hierarchical adherence to antiretroviral therapy over tuberculosis (TB) treatment: a qualitative study of drug–resistant TB/HIV co–infected patients in South Africa. Global Public Health. Accepted April 28, 2014 21. O’Donnell MR, Schluger NW. Long walk to treatment for XDR tuberculosis in South Africa. The Lancet. 2014; 383:1193-4. PMID: 24439236 22. Zelnick JR, Gibbs A, Loveday M, Padayatchi N, O'Donnell MR. Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting. Journal of public health policy 2013;34:388-402. PMID: 23719292 23. O'Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR, Jr. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerging infectious diseases 2013;19:416-24. PMID: 23622055

24. Gopal M, Padayatchi N, Metcalfe JZ, O'Donnell MR. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis. Int J Tuberc Lung Dis 2013;17:1001-7. PMID: 23541151 25. O'Donnell MR, Chamblee S, Moreland JL, Marsh BJ, Narita M, Johnson LS, von Reyn CF Horsburgh CR. Sustained reduction in tuberculosis incidence following a community-based participatory intervention. Public Health Act. 2012; 2 (1) 23-26. 26. Jain P, Hartman TE, Eisenberg N, O’Donnell MR, Kriakov J, Govender K, Makume M, Thaler DS, Hatfull GF, Sturm AW, Larsen MH, Moodley P, and Jacobs WR. ф2GFP10: A high-intensity fluorophage for detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples. J Clin Micro. 2012; 50(4):1362-9. PMID: 22278833

27. O'Donnell MR, Coe A, Bliss C, Lee D, Tumilty S, Skolnik PR, Horsburgh CR, Jr, Cotton D, Saukkonen J. Acceptance of an interferon-gamma release assay by a high-risk urban cohort. Int. J Tuberc Lung Dis. 2011;15(10)1334-9. PMID:

O’Donnell MR 14

22283891

28. Larson EM, O'Donnell M, Chamblee S, Horsburgh CR Jr, Marsh BJ, Moreland JD, Johnson LS, von Reyn CF. Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection. Int J Tuberc Lung Dis. 2011;15:1504-9. PMID: 22008764 29. O'Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N. Extensively Drug-Resistant Tuberculosis in Women, KwaZulu-Natal, South Africa. Emerg Infect Dis. 2011; 17(10):1942-5. PMID: 22000378

30. Brust JC, O’Donnell MR, Metcalfe JZ. TB/HIV: An orphaned disease? Am J Resp Crit Care Med. 2011; 183(11):1441-2. PMID: 21642250 31. Walkey AJ, O’Donnell MR, Soylemez-Wiener R. Linezolid versus Glycopeptide Antibiotics for the Treatment of Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia: A Meta-Analysis of Randomized Controlled Trials. Chest. 2011; 139(5): 11-48-55. PMID: 20864609 32. O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, Naidoo K, Master I, Osburn G, Kvasnovsky C, Shean K, Pai M, Van der Walt M, Horsburgh CR, Dheda K. High Incidence of Hospital Admissions with Multidrug Resistant and Extensively Drug Resistant Tuberculosis among South African Health Care Workers. Ann Intern Med. 2010;153(8):516-22. PMID: 20956708 33. Jarand J, Shean K, O’Donnell M, Loveday M, Kvasnovsky C, Van der Walt M, Adams S, O’Grady J, Willcox P, Zumla A, Dheda K. Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa. Trop Med Int Health. 2010;15(10):1179-84. PMID: 20831672 34. Horsburgh C.R., O'Donnell MR., Chamblee S., Moreland J.L., Johnson J., Marsh B.J., Narita M., Johnson L.S., von Reyn C.F. Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Resp Crit Care Med. 2010;182:420-5. PMID: 20395560 35. Farber HW, Walkey AJ, O'Donnell MR. Ethical issues associated with globalization of placebo-controlled trials in pulmonary arterial hypertension. J Heart Lung Transplant. 2010; 29(7):825-6. Correspondence. PMID: 20456982 36. O'Donnell MR., Chamblee S., Moreland J.L., Johnson J., Marsh B.J., Narita M., Johnson L.S., von Reyn C.F. Horsburgh C.R. Racial Disparities in Primary and Reactivation Tuberculosis in a Rural Community in the Southeastern U.S. Int J Tuberc Lung Dis. 2010;14(6):733-40. PMID: 20487612 37. O'Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR. Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa. Int J Tuberc Lung Dis. 2009; 13:855-61. PMCID: 19555535 38. Zelnick J, O’Donnell M. Expansion of the health workforce and the HIV epidemic. N Eng J Med. 2008; 358:1639, Correspondence PMCID: 18403777 39. Zelnick J, O'Donnell M. The impact of the HIV/AIDS epidemic on hospital nurses in KwaZulu Natal, South Africa: nurses' perspectives and implications for health policy. J Pub Health Policy. 2005; 26(2):163-85 PMCID: 16022210 40. O’Donnell, M. Bacos, D. Bennish, M. Nutritional Response to the 1998 Bangladesh Flood Disaster: Sphere minimum standards in disaster response. Disasters. 2002; 26(3):229-41 PMCID: 12227591

O’Donnell MR 15

Books and Chapters

38. O’Donnell MR, Saukkonen JJ. Chapter 168: Antimycobacterial Agents. Harrison’s Principles of Internal Medicine. 18th Edition. McGraw-Hill Professional. 2011. Chapter 168, p. 1371-9. 39. O’Donnell MR, Saukkonen JJ. Chapter 168: Antimycobacterial Agents. Harrison’s Principles of Internal Medicine. 19th Edition. McGraw-Hill Professional. 2014. Chapter 168, p. 1371-9.

Abstracts

2016 Matt Cummings, Barnabas Bakamutumaho, Julius Lutwama, John Kayiwa, Timothy Byaruhanga, Barbara

Namagambo, Allison Wolf, Joseph F Wamala, Max O'Donnell. Cluster Analysis And Spatial Dynamics Of Influenza-Associated Acute Respiratory Infections In Uganda. American Thoracic Society International Conference, San Francisco, CA.

2016 Matt Cummings, Barnabas Bakamutumaho, Julius Lutwama, John Kayiwa, Timothy Byaruhanga, Barbara Namagambo, Allison Wolf, Joseph F Wamala, Max O'Donnell. Clinical Epidemiology And Seasonality Of Influenza-Associated Severe Acute Respiratory Illness In Uganda, 2010-2015. American Thoracic Society International Conference, San Francisco, CA.

2016 Fahme S, O’Donnell MR. Legionnaire’s Disease In Eight Potentially Epidemiologically-Linked Patients During Two Recent New York City Outbreaks: Case Reports And Literature Review. American Thoracic Society International Conference, San Francisco, CA.

2015 Wolf A, O’Donnell MR, Jain P, Munsamy V, Karim F, Larsen MH, Pym AS, Jacobs WR, Jr. Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods. European Respiratory Congress. Oral Presentation. Amsterdam, Netherlands.

2015 Cummings MJ, Katz SE, Koehne de Gonzalez A, Darmanian AC, O’Donnell MR. Spontaneous Retropharyngeal and Mediastinal Hemorrhage Associated with Wild-Type Transthyretin Systemic Amyloidosis. American Thoracic Society International Conference, Denver, CO.

2014 O’Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Jacobs WR, Larsen MH. Flow cytometry to detect and phenotype drug-resistant Mycobacterium tuberculosis in clinical sputum using a novel reporter phage. American Thoracic Society, San Diego, CA.

2014 O’Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Larsen MH, Jacobs WR. Prospective study of a new rapid reporter mycobacteriophage for the diagnosis of drug-resistant tuberculosis. American Thoracic Society International Conference, San Diego, CA

2014 O’Donnell MR*, Pym A*, Jain P, Munsamy V, Karim F, Wolf A, Larsen MH, Jacobs WR. Reporter mycobacteriophage assay compared to Gene Xpert MTB/RIF for the detection of rifampicin resistant Mycobacterium tuberculosis in human sputum. American Thoracic Society International Conference, San Diego, CA, 2014.

2014 Munsamy V*, Jain P*, O’Donnell MR, Larsen MH, Wolf A, Pym A, Jacobs WR. Development of a Reporter Mycobacteriophage for Rapid Phenotypic Detection of Drug Resistant Mycobacterium tuberculosis in Human Sputum. American Thoracic Society International Conference, San Diego, CA

2014 Lee Chang A, Jain P, Yang H, O’Donnell MR, Jacobs, WR, Jr.. Drug Susceptibility Testing Using Highly Intensive Fluorophage In Mycobacteria Avium Complex. American Thoracic Society International Conference, San Diego, CA.

2014 Chua AT, Zelnick J, O’Donnell MR, Meissner JS. Healthcare Provider Perspectives on Barriers to Tuberculosis Care and Treatment Among Foreign-Born Populations In New York City. American Thoracic Society International Conference, San Diego, CA

2014 Cohen K, Earl AM, Abeel T, Desjardins CA, Maharaj K, Munsamy V, Govender P, O’Donnell, MR, Padayatchi N, Nordenberg D, Cassell GH, Bishai WR, Pym AS. Whole Genome Sequencing M. tuberculosis Strains In KwaZulu-Natal Reveals Multiple Lineages And Extensive Diversity Of MDR And XDR-TB. American Thoracic Society International Conference, San Diego, CA

2014 Cohen KA, El-Hay T, Wyres K, Weissbrod O, Conway T, Munsamy V, O’Donnell MR, Padayatchi, Nordenberg,

O’Donnell MR 16

Cassell GH, Bishai WR, Pym AS. Paradoxical Hypersusceptibility To Beta-Lactams In Drug Resistant Clinical Isolates Of M. Tuberculosis: Elucidation Of Molecular Mechanisms By Whole Genome Sequencing. American Thoracic Society International Conference, San Diego, CA

2014 O’Donnell MR, Pym A, Jain P, Munsamy V, Wolf A, Karim F, Jacobs WR, Larsen MH. Pilot study of a novel reporter phage to predict TB treatment response and measure early emergent TB drug resistance on treatment. Oral Presentation. World Lung Health Conference, Barcelona, Spain.

2014 Daftary A, Padayatchi N, O’Donnell MR. Preferential adherence to antiretroviral therapy over TB treatment: a Qualitative study of drug-resistant TB-HIV co-infected patients in South Africa. World Lung Health Conference, Barcelona, Spain.

2013 Cohen KA, Duffy EY, Maharaj K, McCaffrey PC, O’Donnell MR, Padayatchi N, Pym AS, Bishai WR.Fitness Cost of XDR-TB Strains: Probing with β-Lactam Susceptibility Testing and Deep Sequencing. Keystone Tuberculosis Conference, Whistler, 2013.

2013 Duffy EY, Cohen KA, Maharaj K, McCaffrey PC, O’Donnell MR, Padayatchi N, Pym AS, Bishai WR. Evidence of Significant Polymorphism and Resistance Drift in Extensively Drug Resistant Tuberculosis Patients Treated Over Eight Weeks with Capreomycin.Keystone Tuberculosis Conference, Whistler.

2013 Kalivoda EJ, Jain P, Hartman T, Weinrick B, O’Donnell MR, Jacobs, WR, Jr. Novel Fluorophages for the Detection of Mycobacterium tuberculosis Persister Cells. Keystone Tuberculosis Conference, Whistler.

2013 Chang Lee A, Hicks R, Padayatchi N, Sundkari V, Shah NS, O’Donnell MR. Delay to Diagnosis and Delay to Treatment in South African Children with MDR-TB and HIV. CHEST, Chicago, IL.

2013 Hicks R, Padayatchi N, Sunkari V, Shah NS, O’Donnell MR. Malnutrition Predicts Treatment Outcome and Death in South African MDR-TB HIV Co-Infected Children. Conference on Retrovirals and Opportunistic Infections (CROI), Atlanta GA.

2013 Shama NS, O’Donnell MR, Brust JC, Werner L, Master I, Padayatchi N. Validating Clinical Assignment Of Treatment Outcome In Multi-Drug Resistant Tuberculosis Patients In A High HIV Prevalence Setting. American Thoracic Society International Conference, Philadelphia, PA.

2013 Hicks R, Padayatchi N, Sunkari V, Shah NS, O’Donnell MR. Adverse Drug Reactions in South African MDR-TB HIV Co-Infected Children. American Thoracic Society International Conference, Philadelphia, PA.

2013 Sharma N, Padayatchi N, Werner L, Brust JCM, O’Donnell MR. Temporal Trends in Treatment Outcome and Mortality in Drug-Resistant Tuberculosis and HIV in South Africa. American Thoracic Society International Conference, Philadelphia, PA.

2013 Kalivoda, EJ, Jain P, Hartman T, O’Donnell MR, Weinrick B, Jacobs WR, Jr. Detection Of Mycobacterium Tuberculosis Persister Cells With Novel Fluorophages: Potential For Ex Vivo Characterization Of Persistence. American Thoracic Society International Conference, Philadelphia, PA.

2013 Ascoli C, O’Donnell MR, Wolf A, Moodley P, Horsbrugh CR, Padayatchi N.. Geographic Distribution of XDR-TB in KwaZulu-Natal, South Africa and Relation to Capreomycin Resistance. 44th Union World Conference on Lung Health for the International Union Against Tuberculosis and Lung Disease, Paris, France.

2012 O’Donnell MR, Pillay M, Werner L, Master I, Coovadia Y, Horsburgh CR, Padayatchi N. De Novo Capreomycin Resistance Is Prevalent, Widespread, And Associated With Increased Early Mortality In Extensively Drug-Resistant Tuberculosis (XDR-TB) Patients In KwaZulu-Natal, South Africa. American Thoracic Society International Conference, San Francisco, CA.

2011 O’Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR. “Moxifloxacin is independently associated with improved survival and culture conversion for patients with XDR-TB/HIV.’ American Thoracic Society International Conference, Denver, CO.

2011 O’Donnell MR, Pahuja M, Master I, Werner L, Horsburgh CR, Padayatchi N. Moxifloxacin Improves TB Culture Conversion Rates Extensively Drug Resistant Tuberculosis (XDR-TB) Patients With And Without HIV Co-Infection. American Thoracic Society International Conference, Denver, CO.

2011 Brust JC, O’Donnell MR, Metcalfe JZ. TB/HIV: An Orphan Disease? American Thoracic Society International Conference, Denver, CO.

2011 Gopal M, Naidoo R, O’Donnell MR, Padayatchi N. A retrospective cohort study of clofazimine in the treatment of extensively drug-resistant tuberculosis in South Africa. 43rd Union World Conference on Lung Health for the

O’Donnell MR 17

International Union Against Tuberculosis and Lung Disease, 2010 O’Donnell MR, Zelnick J, Padayatchi N, Werner L, Loveday M, Master I, Osburn G, Dheda K, Horsburgh CR. Women

are at increased risk for extensively drug resistant tuberculosis in KwaZulu-Natal, South Africa. American Thoracic Society International Conference, New Orleans, LA. Oral Presentation.

2010 O’Donnell MR, Padayatchi, N, Grobler A, Master I, Osburn G, Werner L, Horsburgh CR. Treatment Outcomes At 24 Months For Extensively Drug Resistant Tuberculosis (XDR-TB) With And Without HIV Co-infection. American Thoracic Society International Conference, New Orleans, LA.

2010 O’Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR. Improved survival for patients with extensively drug resistant tuberculosis and HIV in South Africa. 17th Annual Conference on Retroviruses and Opportunistic Infections. (CROI).

2010 O’Donnell MR, Padayatchi N, Kvasnovsky C, Master I, Saukkonen J, van der Welt M, Ceglieski P, Horsbrugh CR. Adverse drug reactions in XDR-TB patients with and without HIV infection. 41st Union World Conference on Lung Health for the International Union Against Tuberculosis and Lung Disease

2009 O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, Werner L, Naidoo K, Master I, Osburn G, Kvasnovsky C, Shean K, Pai M, Van der Walt M, Horsburgh CR, Dheda K. High incidence of multidrug resistant and extensively drug resistant tuberculosis among South African health care workers. International AIDS Society Conference (IAS). Cape Town.

2009 Lee D, O’Donnell MR, Saukkonen J, Horsburgh CR, Tumilty S, Coe A, Edwards E, Cotton D. Acceptance of an interferon-gamma release assay for the detection of latent tuberculosis infection by a high risk cohort of injection drug users. American Thoracic Society International Conference, San Diego, CA.

2009 O’Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR. Improved survival for patients with extensively drug resistant tuberculosis and HIV in South Africa. 16th Annual Conference on Retroviruses and Opportunistic Infections. (CROI). Montreal. Oral Presentation.

2007 O’Donnell MR, Padayatchi N, Master I, Osburn G, Horsburgh CR. Clinical treatment outcomes and epidemiologic risk factors for extensive drug resistant tuberculosis patients on treatment in KwaZulu-Natal, South Africa. 38th World Lung Health Conference, Cape Town, South Africa, 2007

2007 O’Donnell MR, von Reyn CF, Chamblee S, Ellerbrock T, Johnson L, Trenschel R, Horsburgh CR. Risk factors for latent and active tuberculosis in a population-based survey in the Southeastern United States. American Thoracic Society Conference, San Francisco, USA.

2004 Zelnick J, O’Donnell MR. The Impact of the HIV/AIDS Epidemic on Public Hospital Nurses in KwaZulu Natal South Africa: Nurses’ Perspectives and Implications for Health Policy. XVth International AIDS Conference, Bangkok, Thailand.

2004 O’Donnell M, Knight S, Campbell L, van Andel P. Knowledge attitudes and beliefs of tuberculosis patients accepting and refusing HIV voluntary counseling and testing in a rural hospital in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2003; 6(10) S182.

2002 HIV case finding at a hospital based TB clinic. Poster presented at IUATLD Africa region conference Durban, South Africa

2002 A variation on DOTS approach: an unorthodox approach. Poster presented at IUATLD Africa region conference Durban, South Africa

INVITED AND/OR PEER-SELECTED PRESENTATIONS AT REGIONAL, NATIONAL OR INTERNATIONAL LEVELS:

Invited Lectures

At Medical Schools and Other Institutions

2016 Pulmonary Grand Rounds Icahn School of Medicine at Mount Sinai, NY, NY

2016 City Wide Tuberculosis Grand Rounds, Weill Cornell Medical College, NY, NY

2016 Implementation Science Grand Rounds, Mailman School of Public Health, Columbia University, NY, NY

O’Donnell MR 18

2016 Visiting Faculty and Invited Lecture, Division of Pulmonary Immunity, University of Cape Town (UCT), South Africa

2016 Visiting Faculty and Pulmonary Work In Progress Research Lecture, Pulmonary Center, Boston University Medical

Center, Boston, MA

2015 Pulmonary Grand Rounds, New York University School of Medicine, NY, NY

2014 Infectious Diseases Grand Rounds, Columbia University Medical Center

2013 Briscoe Lung Club, Invited Speaker

2012 Department of Medicine Grand Rounds, Montefiore Medical Center, Bronx, NY